Picture of Dermapharm Holding SE logo

DMP — Dermapharm Holding SE News Story

0.000.00%
de flag iconLast trade - 00:00
HealthcareBalancedMid CapNeutral

Brief: Dermapharm H1 Adjusted EBITDA EUR 153 Million

Aug 14 (Reuters) - Dermapharm H1 EBITDA margin 25.4%.
* H1 EBITDA EUR 147 million
* H1 adjusted EBITDA margin 26.4%
* H1 revenue EUR 578.5 million

Recent news on Dermapharm Holding SE

See all news